Login

A RADICAL INVESTMENT PLATFORM RESHAPING THE RELATIONSHIP BETWEEN FOUNDERS AND CAPITAL|Khaled Talhouni, Managing Partner, Nuwa Capital 00:10:00

Share On Facebook Share On Twitter

Venture Capitalist investing in emerging markets

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Improving health and well-being in our community|Robert G. Riney,President and CEO,Henry Ford Hospital
00:10:00
Samuel Gregg on the Acton Institute: Bridging Liberty and Religion|Samuel Gregg,Professor,American Institute for Economic Research
00:10:00
Enhancing Sanitation Services in Patos de Minas: COPASA's President Discusses Renegotiation Proposal and Investment Plans | Guilherme Augusto Duarte de Faria, President, Companhia de Saneamento de Minas Gerais Copasa MG.
00:10:00
Artemis Gold's Blackwater Mine on Track with 45% Construction Complete, Focused on Expansion and Sustainability
00:10:00
Leadership Lessons: Speaking Up Where It Counts and Loudly | Michael Hankin, CEO , Brown Advisory LLC.
00:10:00
ArchTIS Ltd reports second strongest revenue quarter ever | DANIEL LAI, CEO, Archtis LtdAR9:ASX
00:10:00
Insights on Gold Focus and Investor Engagement at a One-to-One Conference
00:10:00
Shining Opportunities: Exploring Precious Metals at the 2023 Zurich Summit | Al Fabbro – President, CEO, & Lead Director of Midnight Sun Mining Corp.
00:10:00
"INDepth with Victoria Hardie: Exploring High-Conviction, Scalable Real Asset Strategies at HMC Capital"
00:00:00
Battling Drug Resistance - Maha Farhat, MD, MSc Gilbert S. Omenn Associate Professor of Biomedical Informatics, HMS
00:10:00
Paul Rahe on Soft Despotism and Obama’s Healthcare Proposals| Paul Rahe
00:10:00
Pioneering Safe and Accessible Natural Psychedelics for Healing | Benjamin Lightburn, CEO , Filament Health Corp.

© 2017 - Neuhu+